Skip to main content

Table 1 Therapeutic value of new drugs assessed with the Motola’s rating system

From: Assessment of the therapeutic value of new medicines marketed in Australia

Disease seriousness
Therapeutic innovation Drug for serious diseases Drug for risk factors for serious diseases Drug for non serious diseases Total
Important 7 - - 7 (11.9%)
Moderate 17 - - 17 (28.8%)
Modest 3 1 - 4 (6.8%)
Pharmacological 5 1 - 6 (10.2%)
Technological 22 1 2 25 (42.4%)
TOTAL 54 (91.5%) 3 (5.1%) 2 (3.4%) 59 (100.0%)